ConvaTec Group PLC (LON:CTEC) Receives GBX 306 Average Target Price from Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 306.

CTEC has been the topic of several recent analyst reports. Berenberg Bank reissued a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a research note on Tuesday, April 21st. UBS Group reissued a “buy” rating and set a GBX 375 target price on shares of ConvaTec Group in a research note on Monday, May 18th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, April 8th. Citigroup decreased their target price on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating on the stock in a research note on Monday, May 18th. Finally, Stifel Nicolaus reissued a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, March 11th.

Insider Transactions at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason bought 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were bought at an average price of GBX 201 per share, with a total value of £100,500. Company insiders own 0.98% of the company’s stock.

ConvaTec Group Price Performance

LON CTEC opened at GBX 207.40 on Friday. ConvaTec Group has a 12 month low of GBX 193 and a 12 month high of GBX 294.20. The stock has a market cap of £4.05 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 0.93 and a beta of 0.76. The company’s 50 day moving average is GBX 210.57 and its two-hundred day moving average is GBX 225.10. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 99.96.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.